Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:06 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 553–576 of 716 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Post-Surgical Complication Clear all

Conditions: Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v7, Unresectable Renal Cell Carcinoma
Interventions: Ascorbic Acid, Pazopanib Hydrochloride; Drug
Lead sponsor: Academic and Community Cancer Research United; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 5
States / cities: Peoria, Illinois • Urbana, Illinois • Rochester, Minnesota + 2 more

Conditions: Abdominal Wall Hernia, Pancreatic Diseases, Bowel Disease, Gastric Disease
Interventions: Acetaminophen Injectable Product, Sodium Chloride 0.9%, Intravenous; Drug
Lead sponsor: Kathirvel Subramaniam; Other
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Catheter-Related Infections, Urinary Tract Infections, Urogynecologic Surgery
Interventions: Foley Catheter vs Self-Contained Valved Catheter; Device
Lead sponsor: charbel salamon; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Morristown, New Jersey

Conditions: Prostate Cancer, Erectile Dysfunction, Urinary Incontinence
Interventions: Yoga, Usual Care; Behavioral · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Hines, Illinois

Conditions: Ovarian Cancer
Interventions: Pembrolizumab, Bevacizumab, Cyclophosphamide; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: New York, New York • Houston, Texas

Conditions: Postoperative Pain Management, Urolithiasis
Interventions: Intranasal Ketoralac, Placebo; Drug
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Opioid Use, Prescription Drug Abuse and Dependency, Surgery, Postoperative Pain
Interventions: No opioids at discharge; Behavioral
Lead sponsor: Albany Medical College; Other
Eligibility: 18 Years and older
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Albany, New York

Conditions: Pain, Postoperative, Dental Pain
Interventions: Acetaminophen, Placebo; Drug · Other
Lead sponsor: Nevakar, Inc.; Industry
Eligibility: 17 Years to 55 Years
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Disorder of Knee
Interventions: Oxycodone; Drug
Lead sponsor: International Clinical Research Institute; Other
Eligibility: 18 Years to 75 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: Postoperative Cognitive Dysfunction, POCD
Interventions: Processed EEG; Procedure
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 65 Years and older
Enrollment: 178 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Anastomotic Leaks
Interventions: sponge-based Endoscopic Vacuum Therapy (EVT) using Eso-SPONGE; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Pain, Postoperative
Interventions: Liposomal bupivacaine, Bupivacaine Injection, Placebo; Drug
Lead sponsor: Cooper Norcross Health; Other
Eligibility: 18 Years to 75 Years
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Camden, New Jersey

Conditions: Endometrial Neoplasms
Interventions: Pembrolizumab, Carboplatin, Paclitaxel, Placebo for pembrolizumab, Docetaxel, Cisplatin, External Beam Radiotherapy (EBRT), Cisplatin (as radiosensitizer), Brachytherapy; Biological · Drug · Radiation
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 990 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 29
States / cities: Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 26 more

Conditions: Postsurgical Pain
Interventions: Placebo Injection, AYX1 Injection 110 mg, AYX1 Injection 330 mg; Drug
Lead sponsor: Adynxx, Inc.; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 7
States / cities: Sheffield, Alabama • Phoenix, Arizona • Boynton Beach, Florida + 4 more

Conditions: Medial Patellofemoral Ligament (MPFL) Reconstruction, Sports Injuries in Children, Analgesia, Pain, Postoperative
Interventions: Exparel; Drug
Lead sponsor: Texas Scottish Rite Hospital for Children; Other
Eligibility: 13 Years to 21 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Frisco, Texas

Conditions: Post-operative Pain, Anesthesia
Interventions: methadone, Control (Intra-operative administration of opioids, other than methadone); Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Post-Operative Complications in Cardiac Surgery
Interventions: RBT-1, Placebo; Drug
Lead sponsor: Renibus Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 454 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 31
States / cities: Huntsville, Alabama • La Jolla, California • San Francisco, California + 27 more

Conditions: Hernia, Obesity
Interventions: Surgisis Gold Graft, Control; Device · Procedure
Lead sponsor: Cook Group Incorporated; Industry
Eligibility: 18 Years and older
Enrollment: 402 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2012
U.S. locations: 2
States / cities: Rochester, Minnesota • Richmond, Virginia

Conditions: Abdominal Body Contouring Surgery, Postoperative Pain
Interventions: Active Device (IVIVI SofPulse), Sham Device; Device
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Incisional Hernia
Interventions: Xen Matrix AB; Device
Lead sponsor: C. R. Bard; Industry
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 11
States / cities: Los Angeles, California • San Francisco, California • Atlanta, Georgia + 7 more

Conditions: Acute Pain, Post Operative Pain
Interventions: Pharmacogenetic testing, Pharmacist note with genotype-guided analgesic recommendations, Pharmacist detailed note with genotype-guided recommendations per CPIC guidelines; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older · Female only
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Staphylococcal Infections, Surgical Site Infection
Interventions: XF-73, Placebo; Drug
Lead sponsor: Destiny Pharma Plc; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 7
States / cities: Gainesville, Florida • Pocatello, Idaho • Des Moines, Iowa + 4 more

Conditions: Thoracic Surgery
Interventions: Atorvastatin, Placebo; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Morbid Obesity, Opioid-Related Disorders, Surgery--Complications, Sleep Apnea Syndromes
Interventions: Not listed
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Stanford, California

Search by objective public record fields.

Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by Surgery

IV Acetaminophen for Post-Operative Pain Management in Enhanced Recovery After Surgery (ERAS) Population

Foley Catheter vs a Self-contained Valved Urinary Catheter

A Yoga Program for Patients Undergoing Prostate Cancer Surgery

Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy

The Use of Intranasal Ketoralac for Pain Management (Sprix)

No Opioids PrescrIptions On Discharge After Surgery

A Study of Acetaminophen for Post Surgical Dental Pain

Open-Label Study of Oxycodone/APAP to Treat Post-Operative Pain Following Arthroscopic Knee Surgery

Optimizing Postoperative Cognition the Elderly

Study of Eso-SPONGE for Treating Leaks After Upper Gastrointestinal Surgery

Does a ThoracoLumbar Interfacial Plane (TLIP) Block With Liposomal Bupivacaine Provide TLIP Block in Spinal Surgery

Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)

Study to Evaluate Safety/Efficacy of a Single Pre-Op Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery

Evaluation of Pain Management After Surgery When Using Exparel in the Pediatric Population

Methadone in Ambulatory Surgery

Effect of RBT-1 on Reducing the Risk of Post-Operative Complications in Subjects Undergoing Cardiac Surgery

Evaluation of Surgisis Gold Graft for Incision Reinforcement After Open Bariatric Surgery

PEMF Effects on Pain After Abdominal Body Contouring

Xen Matrix™ AB Surgical Graft in Ventral or Incisional Midline Hernias

Pharmacogenetic-guided Choice of Post-surgery Analgesics

Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal Infection

Study of Atorvastatin Versus Placebo to Reduce Cardiopulmonary Complications After Thoracic Surgery

Recovery of Ventilation After General Anesthesia in Morbidly Obese Patients